Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

Wolf Man' director Leigh Whannell has shared 'Wolf Man' was inspired by the "slow-motion nightmare" of him dealing with a ...

Jazz compositions and charity coalesce in The Mingus Awareness Project. Since 2007, the project has provided opportunities for musicians to perform new arrangements of works by the venerated bassist, ...

Western student applying occupational therapy to her ALS experience to help other families manage their daily lives with physical or cognitive impairment.

Individuals living with ALS are automatically eligible for Medicare when they start receiving Social Security benefits. Medicare should cover most diagnostics and treatments, but this depends on the ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...